Using U.K. Clinical Research to Increase Valuation and Preserve Capital

A panel of seasoned experts sponsored by the British Consulate and the North of England Inward Investment Agency explain how U.S. life science companies can use clinical researchers in the United Kingdom for drug development, medical devices and regenerative medicine. Lunch is provided but space is limited. Please RSVP by Feb. 23 to Dara Khan at